
Healthcare / Pharmaceuticals Sector · BSE
Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.
Price Band
₹51
Issue Size
₹10.20 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹51
at current GMP
Subscribed
—
Open
31 Jan 2020
Close
6 Feb 2020
Allotment
12 Feb 2020
Refund
13 Feb 2020
Demat Credit
14 Feb 2020
Listing
14 Feb 2020
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹51
Band: ₹51
Estimated Listing Price
₹51
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,02,000
Estimated Profit / Lot
₹0
2000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹51 |
| 30 Oct 2026 | — | 0.0% | ₹51 |
| 29 Oct 2026 | — | 0.0% | ₹51 |
GMP is unofficial market data. Not a guarantee of listing performance.
Chandra Bhagat Pharma Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals Sector sector with an aggregate issue size of ₹10.2 Crores. The shares are offered at a price band of ₹51 to ₹51 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,02,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2020-02-14, while un-allotted funds or UPI block mandates will be released on 2020-02-13.
The latest grey market premium for Chandra Bhagat Pharma Limited IPO is ₹0, which indicates an expected listing price of ₹51.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.